You have 9 free searches left this month | for more free features.

lncRNA, mRNA, ESWL,PCNL,SBF2-AS1, FENDRR-19, NLRP3.

Showing 51 - 75 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Vaccination; Infection, COVID-19 Trial (Comirnaty)

Not yet recruiting
  • Vaccination; Infection
  • COVID-19
  • Comirnaty
  • (no location specified)
Aug 4, 2023

SARS-CoV2 Infection, Coronavirus Infection Trial in Hamilton (mRNA- COVID-19, Prevnar13)

Not yet recruiting
  • SARS-CoV2 Infection
  • Coronavirus Infection
  • Hamilton, Ontario, Canada
    McMaster University
Jun 29, 2022

Pneumococcal Infection Trial in Puerto Rico, United States (V110, V114, mRNA-1273)

Recruiting
  • Pneumococcal Infection
  • V110
  • +4 more
  • North Hollywood, California
  • +45 more
Aug 11, 2022

Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

Not yet recruiting
  • HCC
  • No intervention was required for patients or control group in this study
  • (no location specified)
Apr 21, 2023

Outcome of Myocarditis After COVID-19 mRNA Vaccine

Completed
  • Myocarditis
  • data collection in healthcare professionals with COVID-19 mRNA vaccine booster
  • Basel, Switzerland
    University Hospital Basel, Department of Cardiology
Jun 29, 2022

COVID-19, Breakthrough Infection Trial in Taoyuan city (BNT162b2, mRNA-1273, MVC-COV1901)

Active, not recruiting
  • COVID-19
  • Breakthrough Infection
  • BNT162b2
  • +2 more
  • Taoyuan city, Taiwan
    Chang Gung Memorial Hospital
Jul 21, 2022

Pain, Lithiasis Trial (Quadratus lumborum block type III, Erector spinae plane block)

Not yet recruiting
  • Pain
  • Lithiasis
  • Quadratus lumborum block type III
  • Erector spinae plane block
  • (no location specified)
Jul 8, 2023

Depressive Disorder Trial in Tanta (Fluoxetine 20 mg, Dapagliflozin 10mg Tab, Atorvastatin 80mg)

Not yet recruiting
  • Depressive Disorder
  • Fluoxetine 20 mg
  • +2 more
  • Tanta, Shebeen El-Kom, Egypt
    Faculty of Medicine, Menoufia University
Mar 19, 2023

COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),

Not yet recruiting
  • COVID-19
  • +4 more
  • Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
  • Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
  • (no location specified)
Sep 29, 2023

Acute Hepatic Porphyria, Acute Intermittent Porphyria, Porphyria, Acute Intermittent Trial in Worldwide (Givosiran, Placebo)

Completed
  • Acute Hepatic Porphyria
  • +6 more
  • Little Rock, Arkansas
  • +35 more
May 31, 2022

COVID-19 Trial (Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector), Bivalent Recombinant COVID-19 Vaccine

Not yet recruiting
  • COVID-19
  • Bivalent Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector)
  • +2 more
  • (no location specified)
Jul 5, 2022

Tamsulosin, Extracorporeal Shock Wave Lithotripsy, Stone, Kidney Trial in Mansoura (Tamsulosin, Placebo)

Active, not recruiting
  • Tamsulosin
  • +4 more
  • Mansoura, Egypt
    Urology and Nephrology Center
Mar 8, 2023

Urolithiasis Trial in Seoul (Electroconductive and Electrohydraulic types)

Completed
  • Urolithiasis
  • Electroconductive and Electrohydraulic types
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 20, 2023

Percutaneous Nephrolithotomy Trial in Hengyang (one-handed technique)

Recruiting
  • Percutaneous Nephrolithotomy
  • one-handed technique
  • Hengyang, Hunan, China
    The First Affiliated Hospital of University of South China
Jan 30, 2023

Cancer Trial in Anderlecht (Spikevax, Comirnaty)

Recruiting
  • Cancer
  • Spikevax
  • Comirnaty
  • Anderlecht, Belgium
  • +1 more
Aug 30, 2022

COVID-19 Breakthrough Infection in Fully Vaccinated People and

Enrolling by invitation
  • COVID-19 Pneumonia
  • COVID-19
  • Pfizer COVID-19 mRNA vaccine
  • Moderna COVID-19 mRNA vaccine
  • Dallas, Texas
    Methodist Dallas Medical Center
May 24, 2022

Diabetes, Type 2 Trial in Basel (Dapansutrile, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Basel, Switzerland
    University Hospital Basel
Sep 21, 2023

COVID-19 Trial in Hong Kong (BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell), WIBP Omicron Inactivated COVID-19 vaccine

Recruiting
  • COVID-19
  • BIBP Omicron Inactivated COVID-19 vaccine (Vero Cell)
  • +2 more
  • Hong Kong, Hong Kong
    Queen Mary Hospital
May 27, 2022

lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially

Completed
  • Potentially Malignant Lesions, Oral Lichen Planus, Leukoplakia
  • Real-time Polymerase Chain Reaction technique
  • Fayoum, Egypt
    Fayoum University
Feb 7, 2023

COVID-19 Vaccines Trial in Hannover (MVA-SARS-2-ST)

Recruiting
  • COVID-19 Vaccines
  • MVA-SARS-2-ST
  • Hannover, Germany
    Hannover Medical School ZKS - Early Clinical Trial Unit at CRC H
Sep 6, 2022

Immunogenicity, Safety, Efficacy Trial in Savannakhét (SW-BIC-213;SARS-Cov-2., Sinopharm (BIBP);SARS-Cov-2.,

Active, not recruiting
  • Immunogenicity
  • +2 more
  • SW-BIC-213;SARS-Cov-2.
  • +2 more
  • Savannakhét, Sava, Lao People's Democratic Republic
    Savannakhét Provincial hospital
Jan 8, 2023

SARS-CoV-2 Trial in Bengbu (SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine, Saline solution)

Recruiting
  • SARS-CoV-2
  • SARS-CoV-2 Variant (Omicron BA.5) mRNA vaccine
  • Saline solution
  • Bengbu, Anhui, China
    First Affiliated Hospital Bengbu Medical College
Feb 26, 2023

Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among

Completed
  • SARS-CoV-2
    • New York, New York
      Aetion Inc.
    May 5, 2022

    Healthy, Chronic Stable Illness Trial in United States (casirivimab+imdevimab, Moderna mRNA-1273 vaccine)

    Completed
    • Healthy
    • Chronic Stable Illness
    • Little Rock, Arkansas
    • +5 more
    Jan 9, 2023